Cargando…

伴RUNX1突变髓系肿瘤42例临床特征和疗效分析

OBJECTIVE: To investigate the survival and prognostic factors of allogeneic hematopoietic stem-cell transplantation (allo-HSCT) for patients with myeloid neoplasms and RUNX1 mutations. METHODS: From July 2014 to April 2018, the clinical data of forty-two AML/MDS patients with RUNX1 mutations in the...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348223/
https://www.ncbi.nlm.nih.gov/pubmed/30612398
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.12.003